INNOMIND Trademark

Medicines for human purposes, namely, medicines for the treatment of diabetes, obesity, cancer, tumors, cardiovascular diseases, colds, coughs, influenza, respiratory disorders and asthma, gastrointestinal disorders, genitourinary disorders, neurological disorders, allergic reactions, headaches, insomnia, bacterial disorders and eye diseases; Chemical preparations for pharmaceutical purposes, namely, for neurological system related diseases and disorders; Biological preparations for the treatment of neurological system related diseases; Pharmaceutical products for the treatment of central nervous system related diseases; Pharmaceutical preparations for the prevention and treatment of neurological disorders; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for peripheral nervous system; Tranquillizers; Cardiovascular pharmaceutical preparations; Antidepressants; Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations for treating diabetes; Ophthalmic preparations; Pain relief medication; Tumor suppressing agents; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders